Methods for Maintaining Indefinite Healthspan by Restoration and Maintenance of Whole-Organism Bioelectric Coherence

Read full text
Authors: Jack Schaffer
Cited by: 0

Abstract

This defensive publication establishes prior art for methods of preventing and reversing age-related functional decline by targeting whole-organism bioelectric coherence as the primary upstream therapeutic intervention. The disclosure identifies the progressive decline of the organism's integrated bioelectric field — maintained through gap-junction-mediated intercellular communication across tissue boundaries, long-range bioelectric signalling, and coordinated membrane voltage patterning across organ systems — as causally upstream of all currently recognised gerontological mechanisms, including telomere shortening, epigenetic drift, inflammaging, senescent cell accumulation, and age-associated cancer. Therapeutic methods are disclosed for restoring and maintaining whole-organism coherence using systemic pharmacological, physical, cell-based, and closed-loop bioelectric modalities. Diagnostic methods are disclosed for measuring whole-organism bioelectric coherence as a biological age clock upstream of existing gerontological markers. Combination methods are disclosed in which coherence restoration is combined with existing longevity interventions addressing downstream mechanisms. The invention is distinguished from all prior art in gerontology and bioelectric medicine by identifying the integrated whole-organism bioelectric field as the primary therapeutic target for indefinite healthspan, hierarchically distinct from the tissue-level gap-junction connectivity addressed in the applicant's prior disclosures. This document is published as a defensive publication under CC BY-NC-SA 4.0 to establish prior art and prevent the granting of patents on these methods to any party. No patent rights are claimed by the author. Parent prior art disclosure: Methods for Treating Disorders of Tissue Function by Restoration of Morphogenetic Field Connectivity (DOI: 10.5281/zenodo.18854471). Supplementary mechanistic disclosure: Supplementary Mechanistic Claims — Epigenetic Clock Regression, Senescent Cell Reintegration, and Cancer Prevention by Bioelectric Coherence (DOI: 10.5281/zenodo.18856267). Author: Jack Schaffer. March 2026.

Fields of Study & Subjects

Biofield Effects and Biophysics Genetics Aging and Longevity in Model Organisms Telomeres Telomerase and Senescence

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
5 March 2026
Language
EN